Stock ASEP ASEP MEDICAL HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ASEP Medical Holdings Inc.

Equities

ASEP

CA04368A1057

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 20:33:17 25/06/2024 BST 		5-day change 1st Jan Change
0.12 CAD -11.11% Intraday chart for ASEP Medical Holdings Inc. -11.11% -41.46%
05-29 ASEP Medical Holdings Inc. has filed an IPO in the amount of $17.25 million. CI
02-28 Asep Medical Says Its Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis MT

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 28.07 39.76 14.4
Enterprise Value (EV) 1 22.78 36.48 14.2
P/E ratio -4.45 x -7.95 x -1.55 x
Yield - - -
Capitalization / Revenue - - 681 x
EV / Revenue - - 672 x
EV / EBITDA -11,595,546 x -10,952,221 x -2,662,461 x
EV / FCF -40,479,355 x -281,300,992 x -64,909,664 x
FCF Yield -0% -0% -0%
Price to Book 1.54 x 2.57 x 1.21 x
Nbr of stocks (in thousands) 56,130 62,130 70,265
Reference price 2 0.5000 0.6400 0.2050
Announcement Date 30/05/22 01/05/23 30/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 0.0612 - - - 0.0211
EBITDA - - -1.964 -3.331 -5.333
EBIT 1 -0.000353 -0.0281 -2.157 -4.597 -6.611
Operating Margin -0.58% - - - -31,271.78%
Earnings before Tax (EBT) 1 -0.000353 -0.0281 -2.557 -5.846 -9.431
Net income 1 -0.000353 -0.0281 -2.4 -4.525 -8.227
Net margin -0.58% - - - -38,918.3%
EPS - - -0.1124 -0.0805 -0.1322
Free Cash Flow - -0.0116 -0.5626 -0.1297 -0.2188
FCF margin - - - - -1,034.77%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 27/08/21 27/08/21 30/05/22 01/05/23 30/04/24
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 0.11 0.13 - - -
Net Cash position 1 - - 5.29 3.28 0.21
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -0.01 -0.56 -0.13 -0.22
ROE (net income / shareholders' equity) - 20.6% -16.8% -20.2% -38.4%
ROA (Net income/ Total Assets) - -259% -8.78% -9.94% -15.7%
Assets 1 - 0.0109 27.35 45.51 52.46
Book Value Per Share - - 0.3300 0.2500 0.1700
Cash Flow per Share - - 0.0900 0.0300 0
Capex - - 0.07 - 0
Capex / Sales - - - - 5.8%
Announcement Date 27/08/21 27/08/21 30/05/22 01/05/23 30/04/24
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ASEP MEDICAL HOLDINGS INC. Stock ASEP Medical Holdings Inc.
-41.46% 7.54M
MODERNA, INC. Stock Moderna, Inc.
+38.36% 52.5B
LONZA GROUP AG Stock Lonza Group AG
+36.73% 39.31B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.63% 39.01B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+25.46% 28.2B
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 26.57B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.44% 26.2B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+45.09% 14.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.93% 12.62B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-5.30% 11.74B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ASEP Stock
  4. Financials ASEP Medical Holdings Inc.